Avadel Pharmaceuticals plc AVDL
21.64 USD 0.00 (+0.00%)
Feb 13, 2026, 9:30 AM EST
21.64 Day range 21.64
52-week range unavailable
- YTD
- +0.42%
- 1 year
- +140.71%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 169.12M | 27.96M | 0 | 0 | 22.33M | |
| 153.84M | 27.12M | 0 | 0 | 16.59M | |
| -42.40M | -137.85M | -98.56M | -85.55M | 9.14M | |
| -48.83M | -160.28M | -137.46M | -77.33M | 7.03M | |
| -0.51 | -2.00 | -2.29 | -1.32 | 0.13 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 51.37M | 31.17M | 73.98M | 50.71M | 71.72M | |
| 164.24M | 164.70M | 132.78M | 247.26M | 311.64M | |
| 90.39M | 76.96M | 153.93M | 169.02M | 149.37M | |
| 36.95M | 35.38M | 131.02M | 145.00M | 130.52M | |
| 73.85M | 87.74M | -21.14M | 78.24M | 162.27M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -46.91M | -128.51M | -70.30M | -77.31M | -48.73M | |
| 51.78M | -50.09M | 79.70M | 56.93M | -69.72M | |
| 15.97M | 135.34M | 14.54M | 263.00K | 179.68M | |
| 20.20M | -42.81M | 23.27M | -21.01M | 61.95M |